All In Biotech

Drug Trial Radar · NCT07082543

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Jun 30, 2025

Primary completion

Feb 6, 2028

Study completion Mar 6, 2028

Sponsor

Lead sponsor
Azafaros B.V.Industry
Sponsor type
Industry
First posted
Jul 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of GM1 gangliosidosis or GM2 gangliosidosis

Conditions

  • Gangliosidoses, GM2
  • Gangliosidosis, GM1

Interventions

  • AZ-3102Drug

    Nizubaglustat

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in total Scale for the Assessment and Rating of Ataxia (SARA) scoreTime frame: Baseline to month 18
  2. Change from baseline in functional SARA scoreTime frame: Baseline to month 18

Locations

27 sites in 14 countries. Site status is shown where the registry gives one.

  • UCSF Children's Hospital and Research Center at Oakland

    Oakland, California

  • University of Minnesota Medical School

    Minneapolis, Minnesota

  • Mayo Clinic Children's Center - PIN

    Rochester, Minnesota

  • Children's Medical Center Dallas

    Dallas, Texas

  • Lysosomal Rare Disorders Research and Treatment Center

    Fairfax, Virginia

  • Hospital Universitario Austral

    Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina

  • Hospital de Niños de La Santisima Trinidad

    Córdoba, Córdoba Province, Argentina

  • Women's and Children's Hospital

    North Adelaide, South Australia, Australia

  • Instituto Fernandes Figueira

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital de Clinicas de Porto Alegre (HCPA) - PPDS

    Porto Alegre, Rio Grande do Sul, Brazil

  • M.A.G.I.C. Clinic Ltd. Metabolics and Genetics in Calgary

    Calgary, Alberta, Canada

  • AP-HP - Hôpital Armand Trousseau

    Paris, France

  • AP-HP - Hôpital de la Pitié Salpétrière

    Paris, France

  • SphinCS GmbH

    Höchheim, Germany

  • Amrita Institute of Medical Sciences and Research Centre

    Ernākulam, Kerala, India

  • All India Institute of Medical Sciences (AIIMS) - New Delhi

    New Delhi, National Capital Territory of Delhi, India

  • JK Lone Hospital

    Jaipur, Rajasthan, India

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, Italy

  • ULS de Santa Maria,EPE - Hospital de Santa Maria - PPDS

    Lisbon, Portugal

  • ULS de Santo António, EPE - Centro Materno Infantil Norte

    Porto, Porto District, Portugal

  • Hospital Universitario Vall d'Hebron - PPDS

    Barcelona, Barcelona, Spain

  • Hospital Infantil Universitario Niño Jesus - PIN

    Madrid, Madrid, Spain

  • Sahlgrenska universitetssjukhuset Östra

    Gothenburg, Västra Götaland County, Sweden

  • Inselspital - Universitätsspital Bern

    Bern, Canton of Bern, Switzerland

  • Balcali Hastanesi Saglik Uygulama ve Arastirma Merkezi

    Adana, Adana, Turkey (Türkiye)

  • Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi

    Çankaya, Ankara, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi

    Bornova, İzmir, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.